CC Quote, Financials, Valuation and Earnings

Balchem Corp. has a net margin of 4.01% compared to The Chemours Co.'s net margin of 15.06%. The Chemours Co.'s return on equity of -69.66% beat Balchem Corp.'s return on equity of 12.23%.

The Chemours Co. has a consensus price target of $15.78, signalling upside risk potential of 21.74%. On the other hand Balchem Corp. has an analysts' consensus of $200.67 which suggests that it could grow by 30.26%. Given that Balchem Corp. has higher upside potential than The Chemours Co., analysts believe Balchem Corp. is more attractive than The Chemours Co..

The Chemours Co. has a beta of 1.593, which suggesting that the stock is 59.275% more volatile than S&P 500. In comparison Balchem Corp. has a beta of 0.992, suggesting its less volatile than the S&P 500 by 0.809%.

The Chemours Co. has a quarterly dividend of $0.09 per share corresponding to a yield of 3.96%. Balchem Corp. offers a yield of 0.57% to investors and pays a quarterly dividend of $0.87 per share. The Chemours Co. pays 174.61% of its earnings as a dividend. Balchem Corp. pays out 22.16% of its earnings as a dividend. Balchem Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but The Chemours Co.'s is not.

The Chemours Co. quarterly revenues are $1.5B, which are larger than Balchem Corp. quarterly revenues of $267.6M. The Chemours Co.'s net income of $60M is higher than Balchem Corp.'s net income of $40.3M. Notably, The Chemours Co.'s price-to-earnings ratio is 66.47x while Balchem Corp.'s PE ratio is 33.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours Co. is 0.33x versus 4.96x for Balchem Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Element Solutions, Inc. has a net margin of 4.01% compared to The Chemours Co.'s net margin of 5.99%. The Chemours Co.'s return on equity of -69.66% beat Element Solutions, Inc.'s return on equity of 9.44%.

The Chemours Co. has a consensus price target of $15.78, signalling upside risk potential of 21.74%. On the other hand Element Solutions, Inc. has an analysts' consensus of $32.10 which suggests that it could grow by 23.7%. Given that Element Solutions, Inc. has higher upside potential than The Chemours Co., analysts believe Element Solutions, Inc. is more attractive than The Chemours Co..

The Chemours Co. has a beta of 1.593, which suggesting that the stock is 59.275% more volatile than S&P 500. In comparison Element Solutions, Inc. has a beta of 1.333, suggesting its more volatile than the S&P 500 by 33.281%.

The Chemours Co. has a quarterly dividend of $0.09 per share corresponding to a yield of 3.96%. Element Solutions, Inc. offers a yield of 1.23% to investors and pays a quarterly dividend of $0.08 per share. The Chemours Co. pays 174.61% of its earnings as a dividend. Element Solutions, Inc. pays out 31.79% of its earnings as a dividend. Element Solutions, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but The Chemours Co.'s is not.

The Chemours Co. quarterly revenues are $1.5B, which are larger than Element Solutions, Inc. quarterly revenues of $656.1M. The Chemours Co.'s net income of $60M is higher than Element Solutions, Inc.'s net income of $39.3M. Notably, The Chemours Co.'s price-to-earnings ratio is 66.47x while Element Solutions, Inc.'s PE ratio is 26.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours Co. is 0.33x versus 2.52x for Element Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Huntsman Corp. has a net margin of 4.01% compared to The Chemours Co.'s net margin of -0.69%. The Chemours Co.'s return on equity of -69.66% beat Huntsman Corp.'s return on equity of -8.07%.

The Chemours Co. has a consensus price target of $15.78, signalling upside risk potential of 21.74%. On the other hand Huntsman Corp. has an analysts' consensus of $9.92 which suggests that it could fall by -6.47%. Given that The Chemours Co. has higher upside potential than Huntsman Corp., analysts believe The Chemours Co. is more attractive than Huntsman Corp..

The Chemours Co. has a beta of 1.593, which suggesting that the stock is 59.275% more volatile than S&P 500. In comparison Huntsman Corp. has a beta of 0.684, suggesting its less volatile than the S&P 500 by 31.578%.

The Chemours Co. has a quarterly dividend of $0.09 per share corresponding to a yield of 3.96%. Huntsman Corp. offers a yield of 9.43% to investors and pays a quarterly dividend of $0.25 per share. The Chemours Co. pays 174.61% of its earnings as a dividend. Huntsman Corp. pays out 174% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Chemours Co. quarterly revenues are $1.5B, which are larger than Huntsman Corp. quarterly revenues of $1.5B. The Chemours Co.'s net income of $60M is higher than Huntsman Corp.'s net income of -$10M. Notably, The Chemours Co.'s price-to-earnings ratio is 66.47x while Huntsman Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours Co. is 0.33x versus 0.32x for Huntsman Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Innospec, Inc. has a net margin of 4.01% compared to The Chemours Co.'s net margin of 2.92%. The Chemours Co.'s return on equity of -69.66% beat Innospec, Inc.'s return on equity of -0.1%.

The Chemours Co. has a consensus price target of $15.78, signalling upside risk potential of 21.74%. On the other hand Innospec, Inc. has an analysts' consensus of $99.33 which suggests that it could grow by 32.71%. Given that Innospec, Inc. has higher upside potential than The Chemours Co., analysts believe Innospec, Inc. is more attractive than The Chemours Co..

The Chemours Co. has a beta of 1.593, which suggesting that the stock is 59.275% more volatile than S&P 500. In comparison Innospec, Inc. has a beta of 0.931, suggesting its less volatile than the S&P 500 by 6.907%.

The Chemours Co. has a quarterly dividend of $0.09 per share corresponding to a yield of 3.96%. Innospec, Inc. offers a yield of 2.29% to investors and pays a quarterly dividend of $0.87 per share. The Chemours Co. pays 174.61% of its earnings as a dividend. Innospec, Inc. pays out 109.37% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

The Chemours Co. quarterly revenues are $1.5B, which are larger than Innospec, Inc. quarterly revenues of $441.9M. The Chemours Co.'s net income of $60M is higher than Innospec, Inc.'s net income of $12.9M. Notably, The Chemours Co.'s price-to-earnings ratio is 66.47x while Innospec, Inc.'s PE ratio is 98.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours Co. is 0.33x versus 1.05x for Innospec, Inc.. Usually stocks with elevated PS ratios are considered overvalued.